Cunha A, Delou J, Barbosa P, Conceicao J, Souza K, Chagas V
Int J Mol Sci. 2024; 25(20).
PMID: 39456736
PMC: 11507199.
DOI: 10.3390/ijms252010953.
Liu H, Zhang L, Hao L, Fan D
Mol Biotechnol. 2024; .
PMID: 38771419
DOI: 10.1007/s12033-024-01167-w.
Wang Z, Wang M, Huang J, Lin M, Wei P
Dokl Biochem Biophys. 2024; 515(1):29-35.
PMID: 38189882
PMC: 11021325.
DOI: 10.1134/S160767292360029X.
Mohamed Ahmed E, Farag A, Abdelwahed M, Hanbazazh M, Samman A, Ashmawy D
Medicina (Kaunas). 2023; 59(7).
PMID: 37512045
PMC: 10383310.
DOI: 10.3390/medicina59071233.
Matsumoto Y, Fukui T, Horitani S, Tanimura Y, Suzuki R, Tomiyama T
Int J Mol Sci. 2023; 24(14).
PMID: 37511456
PMC: 10380789.
DOI: 10.3390/ijms241411697.
Molecular regulation after mucosal injury and regeneration in ulcerative colitis.
Zheng L, Duan S, Wen X, Dai Y
Front Mol Biosci. 2022; 9:996057.
PMID: 36310594
PMC: 9606627.
DOI: 10.3389/fmolb.2022.996057.
An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.
Liang X, Duronio G, Yang Y, Bala P, Hebbar P, Spisak S
Gastroenterology. 2021; 162(1):209-222.
PMID: 34571027
PMC: 10035046.
DOI: 10.1053/j.gastro.2021.09.044.
Musashi-1-A Stemness RBP for Cancer Therapy?.
Bley N, Hmedat A, Muller S, Rolnik R, Rausch A, Lederer M
Biology (Basel). 2021; 10(5).
PMID: 34062997
PMC: 8148009.
DOI: 10.3390/biology10050407.
Long-term model of colitis-associated colorectal cancer suggests tumor spread mechanism and nature of cancer stem cells.
Tanimura Y, Fukui T, Horitani S, Matsumoto Y, Miyamoto S, Suzuki R
Oncol Lett. 2020; 21(1):7.
PMID: 33240413
PMC: 7681224.
DOI: 10.3892/ol.2020.12268.
The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication.
Padua D, Figueira P, Ribeiro I, Almeida R, Mesquita P
Front Cell Dev Biol. 2020; 8:442.
PMID: 32626705
PMC: 7314965.
DOI: 10.3389/fcell.2020.00442.
The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget's disease.
Song Y, Guerrero-Juarez C, Chen Z, Tang Y, Ma X, Lv C
Cell Res. 2020; 30(10):854-872.
PMID: 32457396
PMC: 7608215.
DOI: 10.1038/s41422-020-0334-5.
Expression Patterns for , and in Cancer Stem-like Cells Isolated from Human Colon Cancer.
Atlasy N, Amidi F, Mortezaee K, Fazeli M, Mowla S, Malek F
Avicenna J Med Biotechnol. 2019; 11(2):156-161.
PMID: 31057717
PMC: 6490413.
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
Wang Q, Shi Y, Zhou K, Wang L, Yan Z, Liu Y
Cell Death Dis. 2018; 9(7):739.
PMID: 29970892
PMC: 6030128.
DOI: 10.1038/s41419-018-0776-6.
Identification and Quantification of Drug-Resistant Cells in Colorectal Tumor and Distal Margin.
Chandramohan K, Pradhan T, Nair S
Indian J Surg Oncol. 2018; 9(2):141-145.
PMID: 29887690
PMC: 5984839.
DOI: 10.1007/s13193-017-0623-8.
Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?.
Morgan R, Mortensson E, Williams A
Br J Cancer. 2018; 118(11):1410-1418.
PMID: 29844449
PMC: 5988707.
DOI: 10.1038/s41416-018-0118-6.
Leucine-rich repeat-containing G protein-coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer.
Harada Y, Kazama S, Morikawa T, Murono K, Yasuda K, Otani K
Oncol Lett. 2017; 14(6):7791-7798.
PMID: 29250176
PMC: 5727605.
DOI: 10.3892/ol.2017.7207.
Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
Wei Q, Ye Z, Zhong X, Li L, Wang C, Myers R
Ann Oncol. 2017; 28(9):2135-2141.
PMID: 28911083
PMC: 5834069.
DOI: 10.1093/annonc/mdx278.
NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.
Karki R, Malireddi R, Zhu Q, Kanneganti T
Cell Cycle. 2017; 16(13):1243-1251.
PMID: 28598238
PMC: 5531621.
DOI: 10.1080/15384101.2017.1317414.
Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.
Chen H, Lu W, Huang C, Ding K, Xia D, Wu Y
Oncotarget. 2017; 8(19):31435-31448.
PMID: 28416756
PMC: 5458220.
DOI: 10.18632/oncotarget.15634.
The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3.
Sakurai T, Higashitsuji H, Kashida H, Watanabe T, Komeda Y, Nagai T
Oncotarget. 2017; 8(15):24762-24776.
PMID: 28160571
PMC: 5421886.
DOI: 10.18632/oncotarget.14983.